Maternal bisphenol A alters fetal endocrine system: Thyroid adipokine dysfunction.

Area of Science:

• Endocrinology
• Toxicology
• Developmental Biology

Background:

• Bisphenol A (BPA) is an environmental contaminant detected in animal species.
• Maternal exposure to endocrine-disrupting chemicals can impact fetal development.

Purpose of the Study:

• To investigate the effects of maternal BPA exposure on the fetal endocrine system, specifically the thyroid-adipokine axis.
• To determine if BPA crosses the placental barrier and affects fetal development.

Main Methods:

• Pregnant rats were orally administered BPA (20 or 40 μg/kg) from gestation day 1-20.
• Serum hormone levels (T4, T3, TSH, GH, IGF1, adiponectin, leptin, insulin, TNFα) were measured in dams and fetuses.
• Thyroid gland histopathology was examined in fetuses.

Main Results:

• Maternal BPA exposure led to decreased serum T4 and T3, and increased TSH in dams and fetuses.
• Fetal thyroid glands showed histopathological changes, including hyperplasia and degeneration.
• BPA exposure suppressed fetal GH, IGF1, and adiponectin, while elevating leptin, insulin, and TNFα.
• Reduced maternal and fetal body weight was observed in BPA-exposed groups, with dose-dependent effects.

Conclusions:

• BPA can cross the placental barrier and disrupt the fetal thyroid-adipokine axis.
• Maternal BPA exposure negatively impacts fetal endocrine function and fat metabolism.
• These findings highlight the potential risks of BPA to fetal development and endocrine health.